FIELD: medicine.
SUBSTANCE: present group of inventions relates to therapy and endocrinology. And it concerns the treatment of heart failure in patients with diabetes. To this end, a pharmaceutical composition comprising an effective amount of neuregulin is administered.
EFFECT: inclusion of neuregulin in a conventional therapy system provides effective treatment of diabetic cardiomyopathy, which is expressed in 55% reduction in mortality in this group of patients.
13 cl, 3 tbl, 1 ex
